FDA Approves Vertex Pharmaceutical’s Journavx as First New Pain Drug in Decades

Vertex Pharmaceuticals received FDA approval for Journavx, marking it the first new acute pain treatment mechanism in over 20 years. Journavx is a first-in-class non-opioid analgesic for moderate to severe acute pain in adults, offering an alternative to opioids.